Oncology APIs for targeted cancer therapies, manufactured to meet stringent purity and handling requirements.
Nilotinib
Tyrosine kinase inhibitor used in chronic myeloid leukemia.
Sorafenib
Tyrosine kinase inhibitor used in cancer treatment.
Ibrutinib
BTK inhibitor used in certain blood cancers.
Ixazomib Citrate
Proteasome inhibitor used in multiple myeloma.
Palbociclib
CDK4/6 inhibitor used in breast cancer.